Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
BIDU-SW
09888
| (FY)Sep 30, 2025 | (FY)Sep 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | (Q3)Jun 30, 2023 | (Q2)Mar 31, 2023 | (Q1)Dec 31, 2022 | (FY)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -12.77%6.23B | 1.14%7.14B | -4.41%1.92B | -21.51%1.4B | -27.64%7.06B | 1.75B | -49.64%1.52B | -16.85%2.01B | -14.33%1.78B | -3.29%9.76B |
| Cost of revenue | -23.02%4.17B | 5.65%5.42B | 10.56%1.44B | -22.49%1.02B | -24.19%5.13B | 1.3B | -44.48%1.22B | -19.63%1.3B | -15.64%1.32B | -6.59%6.77B |
| Gross profit | 19.56%2.06B | -10.84%1.72B | -31.98%481.18M | -18.71%375.46M | -35.46%1.93B | 459.16M | -63.43%299.47M | -11.20%707.41M | -10.36%461.88M | 5.12%2.99B |
| Operating expense | -18.64%1.66B | -17.16%2.04B | -9.89%559.58M | -26.82%558.52M | -23.39%2.47B | 587.97M | -37.84%496.1M | -25.14%621.03M | 4.56%763.22M | -1.41%3.22B |
| Operating profit | 220.23%391.65M | 39.72%-325.75M | -190.76%-78.4M | 39.25%-183.05M | -130.55%-540.39M | -128.81M | -1,047.94%-196.63M | 362.47%86.38M | -40.37%-301.34M | 44.97%-234.39M |
| Net non-operating interest income (expenses) | -90.05%1.66M | 168.10%16.68M | -8,019.23%-2.11M | 231.80%15.24M | 44.33%-24.5M | -5.94M | 38.20%-6.97M | 99.78%-26K | 3.31%-11.56M | 4.62%-44M |
| Non-operating interest income | -60.47%12.02M | 1,620.71%30.41M | 137.73%887K | 694.76%20.61M | 33.36%1.77M | --759K | 7,760.00%766K | -2,898.81%-2.35M | 7,526.47%2.59M | 579.49%1.33M |
| Non-operating interest expense | -24.51%10.36M | -47.74%13.72M | 228.95%3M | -62.07%5.37M | -42.06%26.26M | --6.7M | -31.35%7.74M | -119.44%-2.33M | 18.04%14.16M | -2.16%45.32M |
| Net investment income | 191.03%93.17M | -209.16%-102.34M | 4,012.59%136.58M | 26.96%-87.17M | -76.01%93.75M | 93.47M | -25.23%116.31M | -92.49%3.32M | -596.56%-119.35M | 673.89%390.84M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 105.64%6.07M | 59.97%-107.59M | 0 | 0 | -164.15%-268.81M | -293.42M | -99.93%23K | -100.46%-836K | 115.78%25.42M | 205.83%419.02M |
| Income from associates and other participating interests | 0 | 0 | 0 | 96.58%-2.57M | 0 | 97.88%-116K | 80.46%-1.04M | 83.70%-1.41M | -423.37%-75.17M | |
| Special income (charges) | 18.09%-289.57M | 84.66%-353.5M | 104.55%69.69M | 89.11%-11.88M | -121.80%-2.3B | -458.49M | -141.22%-205.05M | -997.78%-1.53B | 79.83%-109.08M | 78.18%-1.04B |
| Less:Restructuring and mergern&acquisition | ---2.18M | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Other special charges | 7.08%161.59M | -44.63%150.92M | 62.83%-69.69M | -69.58%11.88M | -38.52%272.55M | --399.58M | 62.22%21.38M | -3,039.40%-187.48M | -83.64%39.06M | -79.34%443.28M |
| Less:Write off | -35.75%130.16M | -90.03%202.58M | --0 | --0 | 241.07%2.03B | --58.91M | 155.72%183.67M | 1,191.10%1.72B | -76.82%70.02M | -77.23%595.85M |
| Other non-operating income (expenses) | 74.98%-41.96M | -17.81%-167.7M | -54.17%-62.01M | -470.57%-50.79M | 30.23%-142.35M | -68.27M | -31.58%-47.57M | 18.41%-40.22M | 141.92%13.71M | -123.73%-204.04M |
| Income before tax | 115.48%161.02M | 67.39%-1.04B | 104.29%63.76M | 36.93%-317.66M | -305.36%-3.19B | -861.45M | -571.19%-340M | -12,818.58%-1.48B | 46.75%-503.62M | 83.38%-786.87M |
| Income tax | -61.78%95.63M | 480.98%250.22M | 229.34%7.02M | -81.39%4.16M | 174.37%43.07M | 15.24M | -43.32%10.92M | -874.87%-5.43M | 63.74%22.33M | -97.23%15.7M |
| Net income | 105.07%65.39M | 60.08%-1.29B | 103.84%56.74M | 38.81%-321.81M | -302.80%-3.23B | -876.69M | -763.49%-350.92M | -13,426.96%-1.48B | 45.18%-525.95M | 84.86%-802.57M |
| Net income continuous operations | 105.07%65.39M | 60.08%-1.29B | 103.84%56.74M | 38.81%-321.81M | -302.80%-3.23B | ---876.69M | -763.50%-350.92M | -13,426.96%-1.48B | 45.18%-525.95M | 84.86%-802.56M |
| Noncontrolling interests | 391.08%48.99M | 86.80%-16.83M | 88.23%-2M | -37.15%6.79M | -890.38%-127.52M | -128.72M | 189.68%7.41M | -115.48%-17.01M | 113.88%10.8M | 135.48%16.13M |
| Net income attributable to the company | 101.29%16.4M | 58.99%-1.27B | 104.02%58.74M | 38.78%-328.6M | -279.29%-3.11B | -747.97M | -685.95%-358.33M | -1,110.30%-1.46B | 39.12%-536.75M | 84.42%-818.7M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 101.29%16.4M | 58.99%-1.27B | 104.02%58.74M | 38.78%-328.6M | -279.29%-3.11B | -747.97M | -685.95%-358.33M | -1,110.30%-1.46B | 39.12%-536.75M | 84.42%-818.7M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 101.29%1.61 | 59.15%-124.61 | 103.99%5.75 | 39.59%-32.15 | -274.14%-305.07 | -73.15 | -657.88%-34.7 | -1,094.03%-144 | 39.51%-53.22 | 84.63%-81.54 |
| Diluted earnings per share | 101.29%1.61 | 59.15%-124.61 | 103.99%5.7473 | 39.59%-32.15 | -274.14%-305.07 | -73.1761 | -676.71%-35.0568 | -1,094.03%-144 | 39.51%-53.22 | 84.63%-81.54 |
| Dividend per share | ||||||||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |